Discover 1,164 paid clinical trials in Cincinnati, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
With a focus on a variety of conditions such as lymphoma, cancer, neurological diseases, and sleep apnea, Cincinnati is home to a wide array of clinical studies. The city's leading medical centers are actively recruiting participants, offering paid research opportunities for healthy volunteers or trials for specific health conditions, providing access to innovative treatments and therapies.
Filter
2
Filter results
Results: 1,164
Study of ALTO-300 in MDD
for
Major Depressive Disorder
Location: Cincinnati OH, Chicago IL, Roanoke VA, Hickory NC,
Sponsor: Alto Neuroscience
Sex: All
Age: 18 - 70
Code: NCT05922878
Phase2, Recruiting
Lanadelumab in Long-term Prophylaxis of Acquired Angioedema
for
Angioedema
Location: Cincinnati OH
Sponsor: Bernstein Clinical Research Center
Sex: All
Age: 18+
Code: NCT06818474
Recruiting
An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria
for
Urticaria Chronic
Location: Cincinnati OH, Glenview IL
Sponsor: ARS Pharmaceuticals, Inc.
Sex: All
Age: 18 - 65
Code: NCT06927999
Phase2, Recruiting
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
for
Chronic Spontaneous Urticaria (CSU)
Location: Cincinnati OH, Fairborn OH, New Albany IN,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06868212
Phase3, Recruiting
Non-randomized Observational Study to Evaluate ReX® in the Management of Solid Oral Medication.
for
Any Solid Oral Medication
Location: Cincinnati OH
Sponsor: Dosentrx Ltd.
Sex: All
Age: 18+
Code: NCT06335758
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
for
Acral Lentiginous Melanoma,
Location: Cincinnati OH, Franklin OH, Centerville OH,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT04511013
Phase2, Recruiting
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
for
Castration-Resistant Prostate Carcinoma,
Location: Cincinnati OH, Franklin OH, Centerville OH,
Sponsor: SWOG Cancer Research Network
Sex: Male
Age: 18+
Code: NCT06470243
Phase3, Recruiting
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
for
Bladder Cancer
Location: Cincinnati OH, Knoxville TN, Traverse City MI,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07419295
Phase3, Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
for
Breast Neoplasms, Triple Negative Breast Neoplasms,
Location: Cincinnati OH, Indianapolis IN, Fort Wayne IN,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06966700
Phase3, Recruiting
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
for
Psoriatic Arthritis
Location: Blue Ash OH, Wheelersburg OH, Crossville TN, Lilburn GA,
Sponsor: University of Pennsylvania
Sex: All
Age: 18 - 70+
Code: NCT05669833
Phase3, Recruiting
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
for
Graves' Disease
Location: Florence KY, Indianapolis IN, Bowling Green KY,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18 - 70+
Code: NCT06727604
Phase2, Recruiting
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
for
Epithelial Ovarian Cancer
Location: Blue Ash OH, Dayton OH, Louisville KY, Indianapolis IN,
Sponsor: AstraZeneca
Sex: Female
Age: 18+
Code: NCT07218809
Phase3, Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Blue Ash OH, Lexington KY, Columbus OH, Marion OH,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06283966
Phase3, Recruiting
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7